Related Experiment Video

Updated: Sep 21, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Pulmonary cavitatory tuberculosis in children

D Vijayasekaran1, P Selvakumar, A Balachandran

  • 1Department of Pediatric Respiratory Diseases, Institute of Child Health, Egmore, Madras.

Indian Pediatrics
|September 1, 1994
PubMed

Insights

Pediatric pulmonary cavitary tuberculosis is rare. Adding streptomycin to intensive anti-tuberculosis therapy improved treatment response in children with cavitary lung lesions.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Pulmonary cavitary tuberculosis in children is uncommon and highly infectious.
  • Understanding pretreatment characteristics and treatment responses is crucial for managing this condition.

Purpose of the Study:

  • To analyze the pretreatment characteristics, clinical course, and treatment response to different anti-tuberculosis regimens in children with pulmonary cavitary lesions.
  • To evaluate the effectiveness of various treatment strategies in this pediatric population.

Main Methods:

  • Retrospective analysis of 27 children with cavitary pulmonary lesions treated at a TB Clinic.
  • Children received one of three anti-tuberculosis regimens including isoniazid, rifampicin, pyrazinamide, and streptomycin.
  • Follow-up and surveillance monitored treatment response and compliance in 23 children.

Main Results:

  • Thirty percent of affected children were under 3 years old with lower lobe involvement; older children had upper lobe involvement.
  • Eighty-five percent had a history of contact with an adult with tuberculosis; 70% tested positive for tuberculin.
  • Eleven of 23 children showed persistent radiological lesions after 9 months of therapy, though streptomycin inclusion improved outcomes.

Conclusions:

  • Pulmonary cavitary tuberculosis in children presents with specific demographic and radiological patterns.
  • While standard anti-tuberculosis drugs are used, incorporating streptomycin in the intensive phase may enhance treatment efficacy.
  • Further research is needed to optimize treatment protocols for pediatric pulmonary cavitary tuberculosis.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...